Partners Brett Schuman and Bill Growney outline factors private equity and venture capital firms should consider when evaluating a startup or emerging business in the cannabis industry.
Read the full article.
Related Content
- InsightMay 6, 2024
Which Jobs More Frequently Require Non-Compete Agreements?
- AlertApril 25, 2024
FTC Issues Final Rule Prohibiting Most Post-Employment Non-Compete Agreements
- AlertMarch 19, 2024
Germany Set To Legalize Adult-Use Cannabis
- AlertNovember 8, 2023
Another Domino Falls: Ohio Voters Legalize Adult-Use Cannabis
- AlertAugust 31, 2023
Department of Health and Human Services Recommends that Cannabis be Rescheduled as a Schedule III Drug Under the Controlled Substances Act
- AlertMay 30, 2023
A Mini-Green Wave? Two More States Legalize Adult-Use Cannabis
- AlertMay 16, 2023
New York Releases Significant Changes to Adult-Use Cannabis Regulations
- In the PressJanuary 27, 2023
Cannabis Marketing Proposed Regulations in New York & Neighboring States (Bloomberg Law)
- Awards and RankingsOctober 11, 2024
Daily Journal Names Brett Schuman a Top Trade Secrets Lawyer
- Awards and RankingsJune 13, 2024
The Legal 500 US 2024 Recognizes 44 Goodwin Practices and 186 Lawyers
- Awards and RankingsJune 6, 2024
Chambers USA 2024 Recognizes Goodwin Practices and Lawyers for Exceptional Client Service
- Press ReleaseMay 31, 2024
RIV Capital and Cansortium Announce Business Combination
- Awards and RankingsMay 24, 2024
Neel Chatterjee and Brett Schuman Named Top IP Lawyers by Daily Journal
- In the PressMay 3, 2024
DEA’s Marijuana Rescheduling Plan Has Law Firms High on Expanding Relationships With Cannabis Clients (Law.com)
- WebinarApril 18, 2024
Cannabis Industry Risk Outlook 2024
- In the PressFebruary 26, 2024
Hemp-Derived Delta-9 THC: What’s Next? (Cannabis Business Times)